DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Morgan Stanley Maintains Equal-Weight on Syndax Pharmaceuticals, Raises Price Target to $10

Morgan Stanley maintains Syndax Pharmaceuticals (NASDAQ:SNDX) with a Equal-Weight and raises the price target from $8 to $10.

Benzinga · 03/11/2020 12:32

Morgan Stanley maintains Syndax Pharmaceuticals (NASDAQ:SNDX) with a Equal-Weight and raises the price target from $8 to $10.